Project Grant HT94252510391
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$2.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
This $5,149,107 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides funding to the Fred Hutchinson Cancer Center (also known as the Seattle Cancer Care Alliance) for advanced biomedical research focused on defining human correlates of super-evasive disseminated tumor cells, their pathological relevance, and methods to eradicate them. The 4-year project, running from July 2025 to June 2029, will leverage the...
The federal Project Grant award of $1,578,836.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) in developing and exploiting a third-generation prostate cancer dependency map to identify cancer vulnerabilities and treatment targets. The award, which runs from August 1, 2024 to July 31, 2027, will enable the research organization to conduct innovative...
The Defense Health Agency awarded a $528,000 Project Grant to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to assess the landscape of cell surface targets in metastatic prostate cancer. This 2-year grant, which began on April 15, 2024, is funded through the Military Medical Research and Development program (CFDA 12.420). The project aims to advance biomedical research on innovative therapeutic approaches for cancer, in line with the program's goals of...
The federal Project Grant award, ID HT94252411040, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $879,692 award, with a performance period from September 30, 2024 to September 29, 2027, supports the Fred Hutchinson Cancer Center's research on "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance." This innovative research project aims to develop novel...
The federal Project Grant award with ID HT94252510091 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,927,373.00 grant, awarded on February 15, 2025, supports the development of targeted therapies for metastatic prostate cancers classified by subtypes of DNA repair deficiency at the Fred Hutchinson Cancer Center in Seattle, Washington. As a leading cancer research institution, the Fred Hutchinson Cancer Center conducts...
This federal Project Grant award, valued at $525,847.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Fred Hutchinson Cancer Center in Seattle, Washington to define and exploit essential components of the androgen receptor program operative in castration-resistant prostate cancers. The research aims to transform healthcare for military service members and the broader public by...
This $175,978 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research by the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to study the role of ARID1A mutations in intrahepatic cholangiocarcinoma. The award period is from August 1, 2024 to July 31, 2026. The funding will support the organization's biomedical research and provision of medical care services related to...
The Department of the Army Medical Command awarded a $1,275,000 project grant under the Military Medical Research and Development (CFDA 12.420) program to the Fred Hutchinson Cancer Center in Seattle, Washington. The purpose of this 4-year grant, awarded on November 1, 2024, is to develop a centralized resource that will engage key stakeholders involved in rare tumors of the liver, including oncologists, pathologists, researchers, and patients. The grant will establish a bioresource that...
The University of Washington received a $1,407,738 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2024, supports a 4-year research initiative titled "ENHANCING IMMUNITY IN COLORECTAL CANCER LIVER METASTASES." The project aims to advance biomedical research focused on transforming healthcare for military service members and the broader public, with a...
Fred Hutchinson Cancer Center was awarded a $898,342 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to exploit real-world clinical genomic data to discover biomarkers and address outcome disparity for prostate cancer. Through this award, Fred Hutchinson Cancer Center will leverage existing genomic and clinical data to identify biomarkers...